Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin.

about

Potential Therapeutic Strategies for Hypertension-Exacerbated Cardiotoxicity of Anticancer Drugs Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17β-estradiol in female tumor-bearing spontaneously hypertensive rats.

P2860

Q28070311-C9F95852-6105-4952-B971-C62C5306A8D9 Q55409914-6C3F2D39-6BFC-4F27-AB78-130B6102EC34

P2860

Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin.

Item

http://www.wikidata.org/entity/Q45925907

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Predictors of late-onset heart ...... ents treated with doxorubicin.

@en

Predictors of late-onset heart ...... ents treated with doxorubicin.

@nl

type

Item

label

Predictors of late-onset heart ...... ents treated with doxorubicin.

@en

Predictors of late-onset heart ...... ents treated with doxorubicin.

@nl

prefLabel

Predictors of late-onset heart ...... ents treated with doxorubicin.

@en

Predictors of late-onset heart ...... ents treated with doxorubicin.

@nl

P1476

Predictors of late-onset heart ...... ents treated with doxorubicin.

@en

P2093

Angel Qin

http://www.w3.org/2001/XMLSchema#string

Cheryl L Thompson

http://www.w3.org/2001/XMLSchema#string

Paula Silverman

http://www.w3.org/2001/XMLSchema#string

P2860

Doxorubicin cardiomyopathy

Risk factors for doxorubicin-induced congestive heart failure

Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice.

American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.

Anthracycline-associated cardiotoxicity in survivors of childhood cancer.

Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques.

Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients.

Adjuvant trastuzumab in HER2-positive breast cancer.

P2888

s11764-014-0408-9

P304

252-259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11764-014-0408-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1035071543

http://www.w3.org/2001/XMLSchema#string

P698

25342090

http://www.w3.org/2001/XMLSchema#string

Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin.

about

P2860

P2860

Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698